Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of colchicine on cardiovascular target organ damage in patients with type 2 diabetes
2021-003525-30Phase 2Completed
- Sponsor
- Aarhus University Hospital
- Start
- Oct 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and cardiac morbidity comparing Colchicine with Placebo (2 arms). Primary endpoint: Carotid-femoral pulse wave velocity. Started Oct 2021; status: completed.
02
Drugs
colchicine
03
Conditions
type 2 diabetes mellitus (T2DM)cardiac morbidity
Beyond the preview
Go deeper on 2021-003525-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003525-30.